BTEK.L vs. BIOT.L
BTEK.L (iShares Nasdaq US Biotechnology UCITS ETF) and BIOT.L (L&G Pharma Breakthrough UCITS ETF - USD Accumulating ETF) are both Health & Biotech Equities funds - BTEK.L tracks the NASDAQ Biotechnology TR USD while BIOT.L tracks the Solactive Pharma Breakthrough Value Index Net Total Return. Both are passively managed. Over the past 5 years, BTEK.L returned 6.26%/yr vs 3.12%/yr for BIOT.L. A 0.77 correlation means they provide meaningful diversification when combined. BTEK.L charges 0.35%/yr vs 0.49%/yr for BIOT.L.
Performance
BTEK.L vs. BIOT.L - Performance Comparison
Loading charts...
Different Trading Currencies
BTEK.L is traded in GBP, while BIOT.L is traded in USD. To make them comparable, the BIOT.L values have been converted to GBP using the latest available exchange rates.
Returns By Period
In the year-to-date period, BTEK.L achieves a 14.42% return, which is significantly higher than BIOT.L's 7.49% return.
BTEK.L
- 1D
- -0.14%
- 1M
- 8.62%
- 6M
- 12.42%
- YTD
- 14.42%
- 1Y
- 48.32%
- 3Y*
- 16.28%
- 5Y*
- 6.26%
- 10Y*
- —
BIOT.L
- 1D
- 0.00%
- 1M
- 6.51%
- 6M
- 6.57%
- YTD
- 7.49%
- 1Y
- 31.98%
- 3Y*
- 8.83%
- 5Y*
- 3.12%
- 10Y*
- —
BTEK.L vs. BIOT.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
BTEK.L iShares Nasdaq US Biotechnology UCITS ETF | 14.42% | 23.65% | -0.20% | 0.30% | -1.56% | 0.90% | 23.11% | 21.63% | -6.79% |
BIOT.L L&G Pharma Breakthrough UCITS ETF - USD Accumulating ETF | 7.49% | 26.75% | -3.66% | -13.81% | 2.48% | -2.69% | 24.52% | 8.73% | 0.06% |
Correlation
The correlation between BTEK.L and BIOT.L is 0.82, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.82 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.77 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.78 |
Correlation (All Time) Calculated using the full available price history since Jan 18, 2018 | 0.77 |
The correlation between BTEK.L and BIOT.L has been stable across timeframes, ranging from 0.77 to 0.82 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BTEK.L vs. BIOT.L — Risk / Return Rank
BTEK.L
BIOT.L
BTEK.L vs. BIOT.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Nasdaq US Biotechnology UCITS ETF (BTEK.L) and L&G Pharma Breakthrough UCITS ETF - USD Accumulating ETF (BIOT.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BTEK.L | BIOT.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.88 | ||
| Sortino ratioReturn per unit of downside risk | +1.09 | ||
| Omega ratioGain probability vs. loss probability | 1.40 | 1.27 | +0.14 |
| Calmar ratioReturn relative to maximum drawdown | 6.98 | 3.15 | +3.83 |
| Martin ratioReturn relative to average drawdown | 19.25 | 9.02 | +10.24 |
Loading charts...
Drawdowns
BTEK.L vs. BIOT.L - Drawdown Comparison
The maximum BTEK.L drawdown since its inception was -36.03%, which is greater than BIOT.L's maximum drawdown of -30.68%. Use the drawdown chart below to compare losses from any high point for BTEK.L and BIOT.L.
Loading charts...
Drawdown Indicators
| BTEK.L | BIOT.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -36.03% | -30.68% | -5.35% |
Max Drawdown (1Y)Largest decline over 1 year | -6.89% | -10.21% | +3.32% |
Max Drawdown (3Y)Largest decline over 3 years | -26.39% | -19.56% | -6.83% |
Max Drawdown (5Y)Largest decline over 5 years | -30.86% | -30.68% | -0.18% |
Current DrawdownCurrent decline from peak | -5.23% | -7.02% | +1.79% |
Average DrawdownAverage peak-to-trough decline | -14.66% | -10.48% | -4.18% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.50% | 3.57% | -1.07% |
Volatility
BTEK.L vs. BIOT.L - Volatility Comparison
iShares Nasdaq US Biotechnology UCITS ETF (BTEK.L) and L&G Pharma Breakthrough UCITS ETF - USD Accumulating ETF (BIOT.L) have volatilities of 6.15% and 6.34%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BTEK.L | BIOT.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.15% | 6.34% | -0.19% |
Volatility (6M)Calculated over the trailing 6-month period | 14.68% | 15.32% | -0.64% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.59% | 20.40% | -0.81% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 23.99% | 17.99% | +6.00% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 24.97% | 19.14% | +5.83% |
BTEK.L vs. BIOT.L - Expense Ratio Comparison
BTEK.L has a 0.35% expense ratio, which is lower than BIOT.L's 0.49% expense ratio.
Dividends
BTEK.L vs. BIOT.L - Dividend Comparison
Neither BTEK.L nor BIOT.L has paid dividends to shareholders.
Frequently Asked Questions
BTEK.L and BIOT.L have a correlation of 0.82, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, BTEK.L is cheaper at 0.35% per year. The better choice depends on whether you care most about return, fees, risk, or income.
BTEK.L is cheaper with a 0.35% expense ratio, compared with 0.49% for BIOT.L.
BTEK.L tracks NASDAQ Biotechnology TR USD, while BIOT.L tracks Solactive Pharma Breakthrough Value Index Net Total Return. They also come from different issuers: iShares and L&G. Their fees differ too: 0.35% for BTEK.L and 0.49% for BIOT.L.
Find the right allocation for BTEK.L and BIOT.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer